Balstilimab (BAL)

DRUG2 trials

Sponsors

Agenus Inc., Darren Sigal, MD

Conditions

Advanced CancerColorectal Cancer MetastaticMetastatic Cervical Cancer

Phase 2

BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases

RecruitingNCT07550088

Darren Sigal, MDColorectal Cancer Metastatic

Start: 2026-06-10End: 2028-12-01Target: 17Updated: 2026-08-10

Phase 3

Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)

WithdrawnNCT04943627

Agenus Inc.Advanced Cancer, Metastatic Cervical Cancer

Start: 2021-08-02End: 2021-10-22Updated: 2022-10-05

Related Papers

Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study

Journal of Clinical Oncology2021-12-21169 citations